MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts -- Vallet et al. 110 (10): 3744 Data Supplement - <font size="3">Supplemental materials for: Vallet et al</font> -- Blood

Blood, Vol. 110, Issue 10, 3744-3752, November 15, 2007

MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts
Blood Vallet et al. 110: 3744

Supplemental materials for: Vallet et al

Files in this Data Supplement:

Figure S1. VLA5 expression on MM cells (JPG, 29.0 KB) -
Basal VLA5 expression on MM1.S and INA6 cells was analyzed by flow cytometry, in the presence of CCL3 (5 ng/ml, 6h) and in co-cultures with osteoclasts (12h).